An introduction to the report
All the information pertaining to the market of this rare form of cancer is provided in our recently published report “Malignant Mesothelioma Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” Caused due to the exposure to toxic asbestos, the occurrence of this cancer is higher in countries such as Russia and China. These two countries are pegged to represent the most lucrative markets, owing to the relatively high production of asbestos in these countries. Besides, a high consumption of asbestos in the APAC region is expected to create a sizeable opportunity for key players in this market. Our analysts have observed that the rapid substitution through generics to ease availability and affordability is the key focus area in the global malignant mesothelioma market. We have observed that the application of combination therapies is gaining traction in the market across regions. Documented evidence on the adoption of combination treatments and benefits is being made available to ease patients’ journey through the treatment process. According to our analysts, there is a great need in the market to efficiently meet the requirements for the present treatment regimen. The drugs that are currently in use do not show much response rates. The malignant mesothelioma treatment market requires drugs to increase the current survival rate.
Acquisitions and collaborations are the key strategies adopted by players to develop molecules for the better treatment of malignant mesothelioma. Companies are focusing on collaborating with established research centers and other cancer drug manufacturers to develop drugs. Our research indicates that the hospital pharmacies distribution channel segment is expected to witness a significant rise in revenue share over the forecast period, owing to the increasing direct procurement of mesothelioma drugs by governments to ensure availability in hospital pharmacies and oncology centers.
We have used our in-house epidemiology data based model to estimate the global malignant mesothelioma market numbers
Global Market Study on Malignant Mesothelioma: Cisplatin and Combination Segment Projected to be the Second Most Lucrative Segment by Drug TypeBuy Now
Custom Market Research Services
xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough
Why Choose XploreMR
Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.
Country-wise Analysis & Forecasting
As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.
High Quality At Competitive Pricing
We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information
Global Market Study on Triple-Negative Breast Cancer Treatment: Rising Focus on Combination Therapies Aiding Market Expansion
This XploreMR report examines the ‘Global Triple-Negative Breast Cancer Treatment Market’ for the period 2018–2026. The primary objective of the report is to offer updates and inform ...
Single-Domain Antibody Platforms Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 - 2028
Single-Domain Antibody Platforms Market - Scope of Report A latest publication by XploreMR on the global single-domain antibody platforms market evaluates the opportunities and current market landsca ...